Hamsa Puthalakath

9PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Biological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2025
Development of a novel therapy for systolic heart failure.

Corey Pollock, Xilun Wang, Hussam Alsaraji

|Aug 22, 2024
A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites.

Dimuthu Angage, Jill Chmielewski, Janesha C Maddumage

|Jul 25, 2021
Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis.

Lahiru Gangoda, Robyn L Schenk, Sarah A Best

|Oct 06, 2020
TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis.

Christina Nedeva, Joseph Menassa, Mubing Duan

|Sep 07, 2020
Circulating BiP/Grp78 is a novel prognostic marker for sepsis-mediated immune cell death.

Marcel Doerflinger, Boris Reljic, Joseph Menassa

Pageof 2